tiprankstipranks
Trending News
More News >
Ascelia Pharma AB (SE:ACE)
:ACE
Sweden Market
Advertisement

Ascelia Pharma AB (ACE) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Ascelia Pharma AB’s (ACE) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Ascelia Pharma AB is a Sell.
Ascelia Pharma AB’s (ACE) 20-Day exponential moving average is 3.13, while Ascelia Pharma AB’s (ACE) share price is kr3.2, making it a Buy.
Ascelia Pharma AB’s (ACE) 50-Day exponential moving average is 3.49, while Ascelia Pharma AB’s (ACE) share price is kr3.2, making it a Sell.

Ascelia Pharma AB (ACE) Pivot Points

Nov 02, 2025, 09:05 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.90
2.96
3.06
3.12
3.22
3.28
3.38
Fibonacci
2.96
3.02
3.06
3.12
3.18
3.22
3.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascelia Pharma AB (ACE) Moving Averages

Nov 02, 2025, 09:05 PM
Period
Simple
Exponential
MA5
3.10Buy
3.12Buy
MA10
3.02Buy
3.08Buy
MA20
3.03Buy
3.13Buy
MA50
3.63Sell
3.49Sell
MA100
4.10Sell
3.74Sell
MA200
3.72Sell
3.54Sell
Ascelia Pharma AB’s (ACE) 10-Day exponential moving average is 3.08, while Ascelia Pharma AB’s (ACE) share price is kr3.2, making it a Buy.
Ascelia Pharma AB’s (ACE) 100-Day exponential moving average is 3.74, while Ascelia Pharma AB’s (ACE) share price is kr3.2, making it a Sell.
Ascelia Pharma AB’s (ACE) stock price is kr3.2 and Ascelia Pharma AB’s (ACE) 50-day simple moving average is 3.63, creating a Sell signal.
Ascelia Pharma AB’s (ACE) stock price is kr3.2 and Ascelia Pharma AB’s (ACE) 100-day simple moving average is 4.10, creating a Sell signal.
Ascelia Pharma AB’s (ACE) stock price is kr3.2 and Ascelia Pharma AB’s (ACE) 200-day simple moving average is 3.72, creating a Sell signal.

Ascelia Pharma AB (ACE) Technical Indicators

Nov 02, 2025, 09:05 PM
Name
Value
Implied Action
RSI (14)
49.57
Neutral
STOCH (9,6)
78.21
Neutral
STOCHRSI (14)
78.21
Neutral
MACD (12,26)
-0.13
Sell
ADX (14)
40.82
Neutral
Williams %R
-11.54
Sell
CCI (14)
100.71
Sell
ATR (14)
0.17
-
Ultimate Oscillator
52.48
Neutral
ROC
5.08
Buy
Ascelia Pharma AB’s (ACE) Relative Strength Index (RSI) is 49.57, creating a Neutral signal.
Ascelia Pharma AB’s (ACE) Trend Strength Indicator (ADX) is 40.82, creating a Neutral signal.
Ascelia Pharma AB’s (ACE) Commodity Channel Index (CCI) is 100.71, creating a Sell signal.
Ascelia Pharma AB’s (ACE) Price Rate of Change (ROC) is 5.08, creating a Buy signal.

FAQ

Is ACE a Buy, Hold, or Sell?
Based on ACE’s technical indicators, ACE is a Hold.
    What is ACE’s RSI (14)?
    ACE’s RSI (14) is 49.57, which suggests ACE is a Neutral.
      What is ACE’s MACD?
      ACE’s MACD is -0.13, which suggests ACE is a Sell.
        What is ACE’s 5-day moving average?
        ACE’s 5-day moving average is 3.10, which suggests ACE is a Buy.
          What is ACE’s 20-day moving average?
          ACE 20-day moving average is 3.03, which suggests ACE is a Buy.
            What is ACE’s 50-day moving average?
            ACE’s 50-day moving average is 3.63, which suggests ACE is a Sell.
              What is ACE’s 200-day moving average?
              ACE’s 200-day moving average is 3.72, which suggests ACE is a Sell.
                What is ACE’s Williams % R (14)?
                ACE’s Williams % R (14) is -11.54, which suggests ACE is a Sell.
                  What is ACE’s CCI (14)?
                  ACE’s CCI (14) is 100.71, which suggests ACE is a Sell.
                    What is the share price of Ascelia Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis